TFS appoints Kris O’Brien as VP, Head of Oncology & Rare Diseases, enhancing leadership in clinical trials for complex therapies.
TFS appoints Kris O’Brien as VP, Head of Oncology & Rare Diseases, enhancing leadership in clinical trials for complex therapies.
Leading CRO, TFS HealthScience appoints Victoria Hornagold as VP of Clinical Development Services, enhancing client delivery with a patient-centric focus.
TFS HealthScience achieves top 15% ranking with a Silver Rating from EcoVadis, underscoring our dedication to sustainability and responsible business practices.
TFS HealthScience announces the release of its Sustainability Report 2023, showcasing significant strides in environmental stewardship, social responsibility, and sustainable business practices.
TFS HealthScience, a leading global CRO, announces a noteworthy milestone in its commitment to environmental transparency and sustainability.
LUND, S.E., March 11, 2024 – TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), announces its expansion into the Asia Pacific (APAC) region, with the establishment of an…
Aims to enhance global trial recruitment and operations, reach underrepresented populations, help lower costs and increase speed to commercialization. Will leverage real-world data and evidence (RWD/RWE) and artificial intelligence (AI)-enabled…
LUND, Sweden (Nov. 6, 2023) – TFS HealthScience, a global contract research organization (CRO), announces its strategic investment in Medidata Detect, a comprehensive data surveillance and risk monitoring solution that…
LUND, S.E., 28 Jun 2023 – TFS HealthScience, a premier global contract research organization, is proud to announce that for the fourth consecutive year, it has received a Silver Rating…
LUND, S.E., 27 Mar 2023 – Today, TFS HealthScience, a global contract research organization, unveiled its new office in Lisbon, Portugal, due to growing customer demand. TFS Portugal will increase…
LUND, S.E., 20 Mar 2023 – Today, TFS HealthScience, a global contract research organization, announced its international expansion into Israel to enhance its offerings and geographic reach to support growing…
TFS HealthScience has announced the appointment of Hanna Sandvall as Vice President of Strategic Resourcing Solutions (SRS), one of the company’s comprehensive solutions, which offers functional services, expert insourcing, and targeted recruitment…
LUND, S.E., 23 January 2023 – Today, TFS HealthScience, a global contract research organization, announced a strategic acquisition of Appletree CI Group to enhance the company’s existing expertise in the…
TSF HealthScience has announced the appointment of Patrik Dursand to its Executive Committee as Chief People Officer. Bringing more than 15 years of experience across all facets of human resources…
We are excited to announce that we are strengthening our presence with the brand-new office in central London, in addition to the Uxbridge location. The office provides a modern and…